Elizabeth Hofheinz, M.P.H., M.Ed. • Mon, November 21st, 2016
Move over cell phone…there is another portable device that may want to share that space—the world’s first pocket-sized diagnostic device for osteoporosis. Bone Index Ltd., a company based in Finland, has been granted a U.S. patent for its unique product, known as Bindex.
Bone Index’s CEO, Dr. Ossi Riekkinen said in the November 11, 2016 news release, “Bindex is unique technology. Now we have a total of 19 patents globally including the U.S., China, Japan and large European countries. The United States is a very significant market and we are actively seeking a partner who has the capabilities to take advantage of this unique opportunity. The overall aim is to prevent osteoporotic fractures and improve the quality of life of families in the U.S.”
Dr. Riekkinen told OTW, “Bindex is the first reliable, fast and easy to use point-of-care instrument for osteoporosis diagnostics. We have received 510(k) clearance from FDA for the Bindex to help in osteoporosis diagnosis.”
“Bindex measures the cortical bone thickness of the tibia and the algorithm calculates the Density Index, a parameter which estimates bone mineral density at the hip as measured with DXA [dual-energy X-ray absorptiometry]. Bindex detects osteoporosis with 90% sensitivity and specificity and will significantly help physicians with diagnosis.”